Easton Pharmaceuticals Announces Development of a Blockchain and Cryptocurrency Initiative
March 21, 2018 08:00 ET
|
Easton Pharmaceuticals Inc.
TORONTO, ON, March 21, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals, Inc. (OTC: EAPH), announces it has initiated discussions for the development of a blockchain platform and cryptocurrency that...
Easton Pharmaceuticals Announces It Has Commenced Negotiations With An AMPR Applicant Towards a Marijuana Cultivators / Growers License For Canada; Provides iBliss Update
March 14, 2018 07:00 ET
|
Easton Pharmaceuticals Inc.
TORONTO, ON, March 14, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has commenced negotiations with an AMPR applicant towards a Canadian Marijuana cultivators /...
Easton Pharmaceuticals Announces Key Management Addition With the Appointment of Dr. Daniel Bagi, M.D. to the Board of Directors; Provides Other Updates
February 20, 2018 08:00 ET
|
Easton Pharmaceuticals Inc.
TORONTO, ON, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals (OTC:EAPH) announces the appointment of Dr. Daniel Bagi, MD as Director, President of Business Development. Provides other...
Easton Pharmaceuticals Announces Negotiations for a New Sub-Distribution Agreement for One of Its Woman’s Diagnostic / Treatment Products & Provides Update on Its Alliance Operations
February 06, 2018 08:00 ET
|
Easton Pharmaceuticals Inc.
TORONTO, ON, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals, Inc. (OTC: EAPH), announces it has initiated discussions to transfer part of its licensed woman’s diagnostic and treatment...
Easton Pharmaceuticals Announces The Signing Of Closed Sub-Distribution Agreement for Product VS-Sense
January 25, 2018 08:00 ET
|
Easton Pharmaceuticals Inc.
Agreement Terms Include Several Up-Front Cash Payments Based On Milestones And A Time Limited Recurring Royalty Payment on Each Product Sold TORONTO, ON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Easton...
Easton Pharmaceuticals Announces the Appointment of Mr. Luigi Gentile as Director and Officer to the Company
January 10, 2018 09:00 ET
|
Easton Pharmaceuticals Inc.
This Board Appointment Represents the First of Several Others to Soon be Announced TORONTO, ON, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) is pleased...
Easton Pharmaceuticals & Partner BMV Medica Announce Delivery and Launch of AmnioSense (AL-Sense) in Mexico; Delivery Date for Purchase Order From Windsor Pharmaceuticals for Central America
December 06, 2017 08:00 ET
|
Easton Pharmaceuticals Inc.
TORONTO, ON, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH) and its JV partner, BMV Medica SA de CV, announces product delivery and launch of its licensed AmnioSense...